Skip to main content
Genomics, Proteomics & Bioinformatics logoLink to Genomics, Proteomics & Bioinformatics
. 2018 Apr 22;16(2):152–153. doi: 10.1016/j.gpb.2018.04.001

Corrigendum to “Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine” [Genomics Proteomics Bioinformatics 14 (5) (2016) 298–313]

Shabbir Ahmed 1,a, Zhan Zhou 1,b, Jie Zhou 1,c, Shu-Qing Chen 1,2,⁎,d
PMCID: PMC6112312  PMID: 29691129

The editors regret there was an error in Figure 1 published in Issue 5, 2016. In the figure, “Pharmacodynamics” should be corrected to “Pharmacokinetics”, and “Pharmacokinetics” should be corrected to “Pharmacodynamics”. The corrected Figure 1 is shown below. The editors would like to apologize for any inconvenience caused.

Figure 1.

Figure 1

Effect of genetic polymorphisms on individuals’ drug responses

Pharmacokinetics and pharmacodynamics are main determinants of interindividual differences in drug responses. Genetic polymorphisms in genes related to these processes may result in mild to severe variations in drug responses. ADRs, adverse drug reactions.


Articles from Genomics, Proteomics & Bioinformatics are provided here courtesy of Oxford University Press

RESOURCES